The New Synthetic Serum-Free Medium OptiPASS Promotes High Proliferation and Drug Efficacy Prediction on Spheroids from MDA-MB-231 and SUM1315 Triple-Negative Breast Cancer Cell Lines - Archive ouverte HAL
Article Dans Une Revue Journal of Clinical Medicine Research Année : 2019

The New Synthetic Serum-Free Medium OptiPASS Promotes High Proliferation and Drug Efficacy Prediction on Spheroids from MDA-MB-231 and SUM1315 Triple-Negative Breast Cancer Cell Lines

Domaines

Cancer

Mouniati COLO  : Connectez-vous pour contacter le contributeur

https://hal.science/hal-02091079

Soumis le : vendredi 5 avril 2019-13:45:30

Dernière modification le : vendredi 22 décembre 2023-10:41:31

Consulter le texte intégral

Dates et versions

hal-02091079 , version 1 (05-04-2019)

Identifiants

Citer

Clémence Dubois, Pierre Daumar, Corinne Aubel, Jean Gauthier, Bernard Vidalinc, et al.. The New Synthetic Serum-Free Medium OptiPASS Promotes High Proliferation and Drug Efficacy Prediction on Spheroids from MDA-MB-231 and SUM1315 Triple-Negative Breast Cancer Cell Lines. Journal of Clinical Medicine Research, 2019, 8 (3), pp.397. ⟨10.3390/jcm8030397⟩. ⟨hal-02091079⟩

Exporter

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

PRES_CLERMONT IMOST
74 Consultations
0 Téléchargements

Altmetric

Partager

More